Emmes’ specialties covers a broad range of therapeutic areas with a particular focus on Vaccines and Infectious Diseases, Ophthalmology, Neuroscience, Cell and Gene Therapy, and Rare Disease. With a rich history of scientific inquiry, deep networks in site, investigator, and patient communities, and a strong commitment to delivering outcomes for our clients, Emmes is your full-service CRO partner for your clinical trials.
We are also advancing our legacy of scientific excellence by optimizing all aspects of clinical trials to deliver programs faster and more efficiently through the end-to-end use of technology and AI. A powerful combination delivering the clinical research infrastructure of the 21st century.
Therapeutic Area Expertise
Please click the links below to view profiles of clinical research we’ve conducted across therapy areas.
Vaccines and Infectious Disease
As a full service CRO, Emmes has worked on nearly every epidemic and pandemic since our founding in 1977, including HIV-AIDs, Zika Virus, Ebola, SARS, MERS, H1N1, and COVID-19.
As a full service CRO, Emmes has worked on nearly every epidemic and pandemic since our founding in 1977, including HIV-AIDs, Zika Virus, Ebola, SARS, MERS, H1N1, and COVID-19.
Ophthalmology
Clients seek Emmes’ Ophthalmology clinical research services for a variety of disorders including age-related macular degeneration, glaucoma, diabetic retinopathy, and rare diseases.
Clients seek Emmes’ Ophthalmology clinical research services for a variety of disorders including age-related macular degeneration, glaucoma, diabetic retinopathy, and rare diseases.
Clinical Neuroscience
Clients leverage a broad range of expertise in neurological and psychiatric disorders possesse by our neuroscience therapeutic research unit. We have significant experience in traumatic brain injury, stroke, epilepsy, autism, depression, schizophrenia and substance use disorders.
Clients leverage a broad range of expertise in neurological and psychiatric disorders possesse by our neuroscience therapeutic research unit. We have significant experience in traumatic brain injury, stroke, epilepsy, autism, depression, schizophrenia and substance use disorders.
Rare Disease
Clinical research on rare diseases has proliferated since the passage of the Orphan Drug Act in 1983. Emmes has helped clients conduct rare disease research across several therapeutic areas including infectious diseases, ophthalmology, oncology, autoimmune, neurology, and hematology.
Clinical research on rare diseases has proliferated since the passage of the Orphan Drug Act in 1983. Emmes has helped clients conduct rare disease research across several therapeutic areas including infectious diseases, ophthalmology, oncology, autoimmune, neurology, and hematology.
Cell and Gene Therapy
Navigating drug, device, and biologic regulations is complex. Emmes provides proactive guidance at every stage to reduce risk, protect timelines, and support successful approvals.
Navigating drug, device, and biologic regulations is complex. Emmes provides proactive guidance at every stage to reduce risk, protect timelines, and support successful approvals.
Government
For nearly 50 years, Emmes has partnered with U.S. government agencies to advance public health and scientific discovery. As a full-service contract research organization (CRO), we support the nation’s most critical research efforts—bringing scientific rigor, operational excellence, and a mission-driven mindset to every project.
For nearly 50 years, Emmes has partnered with U.S. government agencies to advance public health and scientific discovery. As a full-service contract research organization (CRO), we support the nation’s most critical research efforts—bringing scientific rigor, operational excellence, and a mission-driven mindset to every project.
Leadership
Leadership
Careers
Careers